Gene · 7072
Papers4,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-Infiltrating Lymphocytes and Cancer Markers in Osteosarcoma: Influence on Patient Survival. | Cancers (Basel) | 2021 | 34885185 | PubTator, text mining | PubMed |
| EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3). | Cancers (Basel) | 2021 | 34885131 | PubTator, text mining | PubMed |
| Changes in Methylation across Structural and MicroRNA Genes Relevant for Progression and Metastasis in Colorectal Cancer. | Cancers (Basel) | 2021 | 34885060 | PubTator, text mining | PubMed |
| Phase Separation of Intrinsically Disordered Nucleolar Proteins Relate to Localization and Function. | Int J Mol Sci | 2021 | 34884901 | PubTator, text mining | PubMed |
| Deficiency of T-Cell Intracellular Antigen 1 in Murine Embryonic Fibroblasts Is Associated with Changes in Mitochondrial Morphology and Respiration. | Int J Mol Sci | 2021 | 34884582 | PubTator, text mining | PubMed |
| Transcription Regulators and Membraneless Organelles Challenges to Investigate Them. | Int J Mol Sci | 2021 | 34884563 | PubTator, text mining | PubMed |
| LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis. | Front Genet | 2021 | 34868263 | PubTator, text mining | PubMed |
| Paclitaxel-induced stress granules increase LINE-1 mRNA stability to promote drug resistance in breast cancer cells. | J Biomed Res | 2021 | 34857678 | PubTator, text mining | PubMed |
| Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer. | Nat Commun | 2021 | 34853315 | PubTator, text mining | PubMed |
| Primary Cutaneous Gamma-Delta T Cell Lymphomas: A Case Series and Overview of the Literature. | Dermatopathology (Basel) | 2021 | 34842638 | PubTator, text mining | PubMed |
| RNA Binding Proteins as Pioneer Determinants of Infection: Protective, Proviral, or Both? | Viruses | 2021 | 34834978 | PubTator, text mining | PubMed |
| Insights into the SARS-CoV-2-Mediated Alteration in the Stress Granule Protein Regulatory Networks in Humans. | Pathogens | 2021 | 34832615 | PubTator, text mining | PubMed |
| Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches. | Cancers (Basel) | 2021 | 34830926 | PubTator, text mining | PubMed |
| Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER. | Int J Gen Med | 2021 | 34819748 | PubTator, text mining | PubMed |
| The 40S-LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity. | Sci Adv | 2021 | 34818049 | PubTator, text mining | PubMed |
| Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update. | Arq Bras Cardiol | 2021 | 34817015 | PubTator, text mining | PubMed |
| Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series. | Orphanet J Rare Dis | 2021 | 34794461 | PubTator, text mining | PubMed |
| DHX15-independent roles for TFIP11 in U6 snRNA modification, U4/U6.U5 tri-snRNP assembly and pre-mRNA splicing fidelity. | Nat Commun | 2021 | 34789764 | PubTator, text mining | PubMed |
| Hemophagocytic lymphohistiocytosis secondary to composite lymphoma: Two case reports. | World J Clin Cases | 2021 | 34786400 | PubTator, text mining | PubMed |
| SARS-CoV-2 nucleocapsid protein interacts with immunoregulators and stress granules and phase separates to form liquid droplets. | FEBS Lett | 2021 | 34780058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7072/papers?page=49